SCREENER COMPARE ANY 2 STOCKS

EXCHANGE TRADED FUND

IBB

iShares Biotechnology ETF

$211.94 ▼ 0.87%

−$1.87 TODAY

FUND FACTS

Manager IShares

Assets $10.72B

Expense ratio 0.44%

Inception Feb 4, 2001

Asset class Equity

Holdings 232

Volume 467.46K

Avg volume 1.55M

ABOUT THIS FUND

The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index. This index comprises publicly traded stocks from companies operating within the U.S. biotechnology sector.

PRICE

$211.94 ▼ DOWN 0.87% (−$1.87)

HOLDINGS

TOP 20 OF 232 · 62.82% OF THE FUND

RANK STOCK WEIGHT SHARES VALUE

01

AMGN Amgen Inc. 8.55% 2.06M $903.06M

02

VRTX Vertex Pharmaceuticals Incorporated 8.04% 1.55M $849.48M

03

GILD Gilead Sciences, Inc. 7.33% 5.16M $774.19M

04

REGN Regeneron Pharmaceuticals, Inc. 5.85% 750.29K $618.1M

05

MRNA Moderna, Inc. 3.94% 2.7M $416.77M

06

ARGX argenx SE 3.76% 386.32K $397.33M

07

NTRA Natera, Inc. 3.08% 1.02M $325.69M

08

RVMD Revolution Medicines, Inc. 2.81% 1.42M $297.09M

09

ALNY Alnylam Pharmaceuticals, Inc. 2.30% 988.58K $243.3M

10

BIIB Biogen Inc. 2.22% 1.09M $235.11M

11

ILMN Illumina, Inc. 2.20% 1.12M $232.41M

12

ONC BeOne Medicines AG 2.01% 591.98K $212.32M

13

INSM Insmed Incorporated 1.84% 1.6M $193.96M

14

INCY Incyte Corporation 1.74% 1.47M $183.98M

15

UTHR United Therapeutics Corporation 1.48% 305.13K $156.44M

16

ROIV Roivant Sciences Ltd. 1.25% 3.84M $132.52M

17

GMAB Genmab A/S 1.22% 3.88M $129.28M

18

ASND Ascendis Pharma A/S 1.13% 459.73K $119.65M

19

NBIX Neurocrine Biosciences, Inc. 1.09% 734.55K $115.15M

20

EXEL Exelixis, Inc. 0.97% 1.81M $103.03M

SECTOR HOLDINGS

TECHNOLOGY IS 100.00% OF THE FUND

Healthcare 100.00%

BY REGION

UNITED STATES IS 86.20% OF THE FUND

United States 86.20%

Netherlands 4.19%

Switzerland 2.39%

Denmark 2.36%

United Kingdom 1.67%

Canada 0.70%

Ireland 0.67%

Germany 0.66%

France 0.53%

China 0.16%

Spain 0.12%

Australia 0.08%

Belgium 0.08%

— Other 0.08%

Italy 0.07%

Luxembourg 0.05%